The goal of our laboratory is to generate a new cancer treatment platform that can be used against many cancers using the oncolytic alphavirus Sindbis Virus (SV). We are working with various in vivo tumor models (pancreatic, colon, ovarian, liver cancer as well as B cell lymphoma) and investigate the impact of SV treatment on the immune response and tumor microenvironment by using state of the art approaches.